Reuters examines upcoming WHO meeting to discuss debate over bird flu research

NewsGuard 100/100 Score

Bird flu experts are scheduled to begin a two-day meeting at the WHO in Geneva on Thursday "to try to settle an unprecedented row over a call to [censor] publication of two scientific studies which detail how to mutate H5N1 bird flu viruses into a form that could cause a deadly human pandemic," Reuters reports in an article describing the debate in detail. "But experts say whatever the outcome, no amount of censorship, global regulation or shutting down of research projects could stop rogue scientists getting the tools to create and release a pandemic H5N1 virus if they were intent on evil," the news service adds.

"The WHO has invited 22 people to this week's meeting, including the researchers who carried out the work, editors of the two journals, Science and Nature, who were asked to hold publication, and representatives from the U.S. National Science Advisory Board for Biosecurity (NSABB) which asked for the papers to be censored," Reuters notes (Kelland/Nebehay, 2/14).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study shows potential for universal flu vaccine with broad antibody response